Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
Authors
Keywords
-
Journal
DIABETOLOGIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-28
DOI
10.1007/s00125-021-05458-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes
- (2021) Andrew B. Crouse et al. Frontiers in Endocrinology
- Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19
- (2021) Sang Youl Rhee et al. Diabetes & Metabolism Journal
- Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis
- (2020) Pan Luo et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Lihua Zhu et al. Cell Metabolism
- Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
- (2020) Yuchen Chen et al. DIABETES CARE
- Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study
- (2020) Qiao Shi et al. DIABETES CARE
- Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
- (2020) Bertrand Cariou et al. DIABETOLOGIA
- Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis
- (2020) Xintao Li et al. HEART
- Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico
- (2020) Omar Yaxmehen Bello-Chavolla et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
- (2020) Francisco J de Abajo et al. LANCET
- Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: a meta-analysis of observational studies
- (2020) Alessandro Mantovani et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies
- (2020) Mohammad Parohan et al. Aging Male
- Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia
- (2020) Jia Li et al. AMERICAN JOURNAL OF INFECTION CONTROL
- The Relationship between Diabetes Mellitus and COVID-19 Prognosis: A Retrospective Cohort Study in Wuhan, China
- (2020) Jian Shang et al. AMERICAN JOURNAL OF MEDICINE
- Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis
- (2020) Luxiang Shang et al. ARCHIVES OF MEDICAL RESEARCH
- Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019
- (2020) Shivani Agarwal et al. DIABETES CARE
- Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: A meta-analysis
- (2020) Li Guo et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Baseline characteristics and risk factors for short-term outcomes in 132 COVID-19 patients with diabetes in Wuhan China: A retrospective study
- (2020) Yumin Li et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study
- (2020) Sufei Wang et al. DIABETOLOGIA
- Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis
- (2020) Yue Zhou et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Baseline use of angiotensin-converting enzyme inhibitor/AT1 blocker and outcomes in hospitalized coronavirus disease 2019 African-American patients
- (2020) Priyank Shah et al. JOURNAL OF HYPERTENSION
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Obesity is a risk factor for developing critical condition in COVID‐19 patients: A systematic review and meta‐analysis
- (2020) Mária Földi et al. Obesity Reviews
- Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease
- (2020) Hadith Rastad et al. Diabetology & Metabolic Syndrome
- The impact of type 2 diabetes and its management on the prognosis of patients with severe COVID ‐19
- (2020) Zihui Xu et al. Journal of Diabetes
- Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
- (2020) Naomi Holman et al. Lancet Diabetes & Endocrinology
- Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study
- (2020) Emma Barron et al. Lancet Diabetes & Endocrinology
- The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study
- (2020) Rinkoo Dalan et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
- (2020) Sebastiano Bruno Solerte et al. DIABETES CARE
- Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19
- (2020) Jacqueline Seiglie et al. DIABETES CARE
- Haemoglobin A1c is a predictor of COVID‐19 severity in patients with diabetes
- (2020) Eugene Merzon et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis
- (2020) Diana C. Sanchez-Ramirez et al. RESPIRATORY MEDICINE
- Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland
- (2020) Stuart J McGurnaghan et al. Lancet Diabetes & Endocrinology
- Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study
- (2019) Oana P Zaharia et al. Lancet Diabetes & Endocrinology
- GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence
- (2018) Holger J. Schünemann et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method
- (2014) Joanna IntHout et al. BMC Medical Research Methodology
- Assessing Bias in Studies of Prognostic Factors
- (2013) Jill A. Hayden et al. ANNALS OF INTERNAL MEDICINE
- GRADE guidelines: 3. Rating the quality of evidence
- (2011) Howard Balshem et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now